Back

Toxoplasma gondii associates with Benign Prostatic Hyperplasia and induces prostatic hyperplasia and urinary dysfunction in mice

Stanczak, E. F.; Fuller, T. D.; Strand, D. W.; Xia, H.; Strobel, O. R.; Heredero Bermejo, I.; Arrizabalaga, G. W.; Jerde, T. J.

2026-04-24 pathology
10.64898/2026.04.23.720409 bioRxiv
Show abstract

ObjectivesBenign Prostatic Hyperplasia (BPH) is the non-cancerous enlargement of the prostate accompanied by lower urinary tract symptoms, affecting 50% of men by the age of 501,2. Advanced highly symptomatic BPH exhibits large epithelial glandular nodules with microglandular/atypical adenomatous hyperplasia, but how these features form is unknown3. Our lab has reported that the common parasite Toxoplasma gondii can infect the prostate and induce glandular nodule formation in mice3. The objective of this study is to determine if T. gondii exposure in humans correlates to BPH and nodule formation and if it induces urinary dysfunction concurrent in the mouse model. MethodsWe assessed Toxoplasma exposure by serum ELISA in patients with BPH and non-BPH donor controls, and compared seropositivity rates between the groups. We further assessed the histopathology of these patients for the presence of inflammation and epithelial glandular nodule formation and compared Toxoplasma positive and negative samples. We determined voiding function in Toxoplasma-infected mice between 14 and 60 days of infection with void spot with Void Whizzard software. ResultsMen diagnosed with BPH are more likely to be seropositive for Toxoplasma than age-matched undiagnosed donor controls. In addition, BPH patients that are seropositive for Toxoplasma are more likely to exhibit glandular nodule formation with microglandular / adenomous hyperplasia than seronegative BPH patients. In animal studies, Toxoplasma infection results in abnormal void patterns concurrent with microglandular hyperplasia and nodule formation. ConclusionsThese results suggest that Toxoplasma may be contributing to BPH pathology and lower urinary tract dysfunction in both humans and mice, opening new insights into the development of this important disease. The results also serve to further characterize this model of prostatic hyperplasia and define it as a potential urinary dysfunction model.

Matching journals

The top 4 journals account for 50% of the predicted probability mass.

1
The Prostate
11 papers in training set
Top 0.1%
29.2%
2
PLOS ONE
4510 papers in training set
Top 14%
13.0%
3
Cureus
67 papers in training set
Top 0.4%
7.2%
4
Modern Pathology
21 papers in training set
Top 0.1%
6.7%
50% of probability mass above
5
Scientific Reports
3102 papers in training set
Top 21%
5.1%
6
Biology of Sex Differences
29 papers in training set
Top 0.1%
3.8%
7
Journal of Clinical Pathology
12 papers in training set
Top 0.1%
3.4%
8
American Journal of Physiology-Renal Physiology
25 papers in training set
Top 0.1%
2.5%
9
The Journal of Clinical Endocrinology & Metabolism
35 papers in training set
Top 0.8%
1.3%
10
Journal of Pathology Informatics
13 papers in training set
Top 0.2%
1.3%
11
Biology of Reproduction
28 papers in training set
Top 0.2%
1.0%
12
The Journal of Steroid Biochemistry and Molecular Biology
10 papers in training set
Top 0.2%
1.0%
13
Frontiers in Pediatrics
29 papers in training set
Top 0.6%
0.9%
14
Journal of Translational Medicine
46 papers in training set
Top 2%
0.9%
15
Cells
232 papers in training set
Top 5%
0.8%
16
PLOS Neglected Tropical Diseases
378 papers in training set
Top 5%
0.8%
17
Nature Communications
4913 papers in training set
Top 63%
0.8%
18
Sexually Transmitted Infections
21 papers in training set
Top 0.4%
0.7%
19
BMC Medicine
163 papers in training set
Top 8%
0.5%
20
Heliyon
146 papers in training set
Top 8%
0.5%
21
Microorganisms
101 papers in training set
Top 3%
0.5%
22
British Journal of Cancer
42 papers in training set
Top 2%
0.5%
23
Journal of Cellular and Molecular Medicine
18 papers in training set
Top 1%
0.5%